HALONOVA
HALONOVA 1
HALONOVA 2
HALONOVA 3

HALONOVA

HALONOVA Tablet by NovaTech Sciences contains Fluoxymesterone (CAS 76‑43‑7). Trusted manufacturer, supplier, and exporter of pharmaceutical‑grade anabolic support for strength, performance, and hormone balance.

CAS Number: 76-43-7

HALONOVA (Fluoxymesterone 5 mg) is indicated for testosterone replacement therapy in individuals with clinically low testosterone levels. It supports androgen balance, muscle preservation, strength maintenance, and overall androgen function in medically supervised cases. Used in controlled treatment plans, HALONOVA helps improve low testosterone-related symptoms safely.

HALONOVA by Nova Techsciences is presented as an oral tablet containing Fluoxymesterone 5 mg. Fluoxymesterone is a synthetic androgenic and anabolic steroid identified by CAS Number 76-43-7. Its molecular formula is C20H29FO3, with a molecular weight of approximately 336.44 g/mol.

This page provides general product-identification, quality and safety information. HALONOVA should only be described according to verified regulatory documentation and must not replace authorised prescribing information, an approved patient leaflet or advice from a qualified healthcare professional.

HALONOVA Product Overview

Important product information includes:

  • Product name: HALONOVA
  • Active compound: Fluoxymesterone
  • Strength: 5 mg per tablet
  • Dosage form: Oral tablet
  • CAS Number: 76-43-7
  • Brand: Nova Techsciences

The product label should clearly identify its full formulation, inactive ingredients, tablet quantity, batch number, manufacturing date, expiry date and approved storage conditions. Information published on the website should remain consistent with the packaging, Certificate of Analysis and batch-release records.

Quality Control and Traceability

Each HALONOVA batch should be supported by appropriate pharmaceutical quality checks. These may include raw-material identification, active-ingredient assay, tablet content uniformity, dissolution testing, impurity analysis, microbiological assessment and packaging-integrity verification.

A unique batch number should connect the finished product with its manufacturing history and laboratory results. Claims concerning quality, purity or manufacturing standards should only be published when supported by current and verifiable documentation.

For the United Kingdom, Netherlands and other European markets, Nova Techsciences should clearly state the product’s marketing-authorisation status, legal supply category, responsible manufacturer and adverse-event reporting process.

Important Safety Information

Fluoxymesterone belongs to the androgenic-steroid category. Oral androgenic steroids in this class have been associated with potentially serious liver injury, including prolonged cholestasis and, with long-term exposure, certain liver abnormalities and tumours.

HALONOVA should not be presented for unsupervised hormone use, bodybuilding or performance enhancement. It is also listed as a prohibited anabolic agent under the 2026 World Anti-Doping Agency Prohibited List.

Related Nova Techsciences Products

NOVA-T3

NOVA-T3 contains Liothyronine Sodium, identified by CAS Number 55-06-1. It is a thyroid-hormone medicine used in selected clinical circumstances. Accurate strength identification and thyroid-function monitoring are essential, and it should not be promoted for unsupervised weight loss or metabolism enhancement.

NOVA-T4

NOVA-T4 is presented as a Levothyroxine Sodium tablet. The sodium salt is associated with CAS Number 55-03-8, while CAS Number 51-48-9 refers to levothyroxine itself. These identifiers should be clearly distinguished across the product page, label, schema and technical records.

NOVABOL

NOVABOL contains Oxandrolone, identified by CAS Number 53-39-4. Oxandrolone is an anabolic-androgenic steroid and requires separate prescribing information, contraindications, liver-related warnings and regulatory assessment. It should not be treated as interchangeable with Fluoxymesterone or other oral androgenic compounds.

NOVAMETH

NOVAMETH contains Methandienone 10 mg, identified by CAS Number 72-63-9. Methandienone is an orally active anabolic-androgenic steroid with a distinct chemical and safety profile. Its page should prioritise regulatory status, liver and cardiovascular precautions, batch documentation and warnings against non-medical use.

NOVAMOREN

NOVAMOREN is presented as an MK-677 product containing Ibutamoren Mesylate, associated with CAS Number 159752-10-0. Ibutamoren is a non-peptide growth-hormone secretagogue and differs substantially from anabolic steroids and thyroid medicines. Its regulatory status and supporting clinical evidence should be stated accurately.

HALONOVA should ultimately be presented through accurate chemical identification, transparent batch documentation, balanced risk information and clearly stated regulatory status.

Important Information & FAQs

Precautions & Contraindications

Precautions

  • Use HALONOVA only under medical supervision.
  • Follow prescribed dosage; avoid self-medication.
  • Inform your doctor of all medications, supplements, or steroids.
  • Avoid alcohol and recreational substances to reduce liver strain.
  • Keep out of reach of children; store in a cool, dry place.
  • Seek medical attention if unusual symptoms occur such as difficulty breathing, swelling, or severe mood changes.
  • Do not exceed recommended dosage to minimize risk of adverse effects.

Contraindications

  • Do not use if allergic to Fluoxymesterone or any component of HALONOVA.
  • Not recommended for individuals with liver, kidney, or heart disorders.
  • Not suitable for pregnant or breastfeeding women.
  • Discontinue and seek medical advice if unusual or severe symptoms appear.
  • Use only under medical supervision.
HALONOVA

Related Products